Find Articles



Return to:Diabetes Articles
Or:Recent Diabetes Articles

Pfizer 3Q Profit Falls on Exubera Charge


http://www.forbes.com/feeds/ap/2007/10/18/ap4234158.html

Forbes - Sales of diabetes drug Exubera have been disappointing for both the company and Wall Street since its launch. The company said it will return licensing rights to partner Nektar Therapeutics (nasdaq: NKTR - news - people ) Inc. and ...



Article Finder:

October 18, 2007 05:47:00 AM
Article Directory